Trends and survival of malignant mesothelioma across racial groups between 2000-2019: A real-world study

被引:0
|
作者
Al Armashi, Abdul Rahman
Alkrekshi, Akram
Al Zubaidi, Anas
Hammad, Faris
Elantably, Dina
Mahmood, Omar
Vien Truong
Ngo, Tam N. M.
Bruno, Debora S.
机构
[1] Case Western Reserve Univ, Case Comprehens Canc Ctr, Seidman Canc Ctr, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Dept Hematol & Oncol, MetroHlth Med Ctr, Cleveland, OH 44106 USA
[3] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[4] Case Western Reserve Univ, Univ Hosp, Seidman Canc Ctr, Cleveland, OH 44106 USA
[5] Case Western Reserve Univ, MetroHlth Med Ctr, Cleveland, OH 44106 USA
[6] UCSF Fresno, Fresno, CA USA
[7] Dept Internal Med, Philadelphia, PA USA
[8] Pham Ngoc Thach Univ Med, Ho Chi Minh City, Vietnam
[9] Univ Hosp, Case Comprehens Canc Ctr, Cleveland, OH USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e20539
引用
收藏
页数:1
相关论文
共 49 条
  • [1] Tumor Mutations Across Racial Groups in a Real-World Data Registry
    Kamran, Sophia C.
    Xie, Jamie
    Cheung, Alexander T. M.
    Mavura, Mnaya Y.
    Song, Hanbing
    Palapattu, Elina L.
    Madej, Joanna
    Gusev, Alexander
    Van Allen, Eliezer M.
    Huang, Franklin W.
    [J]. JCO PRECISION ONCOLOGY, 2021, 5 : 1654 - 1658
  • [2] A SEER program study of survival trends in Merkel cell carcinoma of the eyelid: 2000-2019
    Nudelman, Nicole T.
    Ekhator, Nehikhare
    Rothschild, Michael
    Wladis, Edward J.
    [J]. ORBIT-THE INTERNATIONAL JOURNAL ON ORBITAL DISORDERS-OCULOPLASTIC AND LACRIMAL SURGERY, 2024, 43 (03): : 290 - 295
  • [3] Real-World Survival Outcomes of Patients with Malignant Pleural Mesothelioma by Choice of Second-line Therapy
    Kerrigan, K.
    Chipman, J.
    Jo, Y. J.
    Haaland, B.
    Johnson, E.
    Puri, S.
    Varghese, T.
    Akerley, W.
    Patel, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S199 - S199
  • [4] Immune-Checkpoint Inhibitors for Malignant Pleural Mesothelioma: A French, Multicenter, Retrospective Real-World Study
    Assie, Jean-Baptiste
    Crepin, Florian
    Grolleau, Emmanuel
    Canellas, Anthony
    Geier, Margaux
    Grebert-Manuardi, Aude
    Akkache, Nabila
    Renault, Aldo
    Hauss, Pierre-Alexandre
    Sabatini, Marielle
    Bonnefoy, Valentine
    Cortot, Alexis
    Wislez, Marie
    Gauvain, Clement
    Chouaid, Christos
    Scherpereel, Arnaud
    Monnet, Isabelle
    [J]. CANCERS, 2022, 14 (06)
  • [5] A Real-World Analysis of the Use of Systemic Therapy in Malignant Pleural Mesothelioma and the Differential Impacts on Overall Survival by Practice Pattern
    Kerrigan, Kathleen
    Jo, Yeonjung
    Chipman, Jonathan
    Haaland, Benjamin
    Puri, Sonam
    Akerley, Wallace
    Patel, Shiven
    [J]. JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (03):
  • [6] Real-world safety of nivolumab in patients with malignant pleural mesothelioma in Japan: post-marketing surveillance study
    Fujimoto, Nobukazu
    Akamatsu, Ayumi
    Honda, Chikara
    Aoki, Miki
    Ohe, Yuichiro
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024,
  • [7] Real-World Survival Outcomes of Patients with Malignant Pleural Mesothelioma by Physician's Choice of First-line Platinum Chemotherapy
    Kerrigan, K.
    Chipman, J.
    Jo, Y. J.
    Haaland, B.
    Johnson, E.
    Puri, S.
    Varghese, T.
    Akerley, W.
    Patel, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S122 - S123
  • [8] Characteristics and survival trends in Finnish multiple myeloma patients—a nationwide real-world evidence study
    Iiro Toppila
    Tatu Miettinen
    Mariann I. Lassenius
    Juha Lievonen
    Melissa Bauer
    Pekka Anttila
    [J]. Annals of Hematology, 2021, 100 : 1779 - 1787
  • [9] Pertussis in Mexico from 2000 to 2019: A real-world study of incidence, vaccination coverage, and vaccine effectiveness
    Sanchez-Gonzalez, Gilberto
    Luna-Casas, Gerardo
    Mascarenas, Cesar
    Macina, Denis
    Vargas-Zambrano, Juan C.
    [J]. VACCINE, 2023, 41 (41) : 6105 - 6111
  • [10] Real-world evidence of the impact of immunotherapy (IT) on overall survival (OS) of patients (p) with malignant pleural mesothelioma (MPM) adjusted for tumor histology
    Cedres Perez, S. M.
    A. Valdivia, A.
    Assaf Pastrana, J. D.
    Iranzo Gomez, P.
    Callejo Perez, A.
    Pardo Aranda, N.
    Navarro Mendivil, A. F.
    Martinez-Marti, A.
    Priano, I.
    Ucha Hermida, J. M.
    Garcia-Galea, E.
    Gonzalo, J.
    Caro, R.
    Carbonell, C.
    Amat, R.
    Dienstmann, R.
    Felip, E.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1134 - S1134